Over the last 30 years, SGS has performed over 2.000 Phase I to III studies, covering numerous therapeutic areas with a particular focus on the following therapeutic areas and diseases:
EUROPEt: +33 15 378 18 79 E-mail
NORTH AMERICAt: +1 877 677 2667 E-mail
ASIAt: +65 63790130 E-mail